Scoggin Management LP Vaxxinity, Inc. Transaction History

Scoggin Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.43 - $4.24 $929 - $2,756	650 Added 0.44%	150,000 $340,000
Q4 2022 Feb 13, 2023	SELL	$1.31 - $2.62 $133,382 - $266,765	-101,819 Reduced 40.54%	149,350 $209,000
Q3 2022 Nov 14, 2022	SELL	$1.64 - $2.48 $49,200 - $74,400	-30,000 Reduced 10.67%	251,169 $497,000
Q4 2021 Feb 11, 2022	BUY	$5.55 - $18.46 $1.56 Million - $5.19 Million	281,169 New	281,169 $1.58 Million

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Scoggin Management LP, based on Form 13F filings with the SEC.

Stay updated on Scoggin Management LP with notifications on news.